Psilocybin therapy uses the psychoactive compound found in certain mushrooms to facilitate profound changes in the brain. This approach is gaining attention for its potential to treat conditions like depression and anxiety by opening new neural pathways. Learn how this therapy works and its recent advancements.

Understanding Psilocybin Therapy

Psilocybin mushrooms are colloquially known as “magic mushrooms” or “shrooms,” and have been used for thousands of years as a spiritual and medicinal tool among Indigenous populations.1

This approach is based on the effects psilocybin has on the central nervous system and on how it breaks down the “ego” and opens up new neural paths in the brain that can lead to change.2

What a Psilocybin Therapy Session Looks Like

In psilocybin therapy, a patient takes psilocybin under the supervision of a therapist. This occurs in a safe, controlled setting where the patient embarks on a psychedelic journey. The therapist supports the experience by staying in contact and asking guiding questions throughout the session.

The session lasts six to eight hours, which is the full duration of the drug’s effects; in some situations, patients may use the substance more than once. The general standard is that the psychedelic journey occurs a single time, with standard talk therapy often continuing after.

The History of Psilocybin Therapy

For many people, the notion of using a psychedelic drug for therapy might sound like something counterculture or fringe. That’s not the case at all!

Psilocybin therapy is both studied and used by highly legitimate medical establishments such as Johns Hopkins.3 In fact, it was John Hopkins University that first received regulatory approval for psychedelic research in the year 2000, decades after the research and therapy were banned by the U.S. government in 1970.4

In 2006, the first research paper by Johns Hopkins was published on the positive long-term impact of using psilocybin in a therapeutic study.5 Since then, dozens of studies and academic papers6 have been published, with the overarching theme that the therapy offers solid, long-term positive impact for patients with a variety of conditions.

In 2021, Hopkins received a federal grant7 for psychedelic treatment research, which was within a similar timeframe of some states beginning to decriminalize it. Currently, legislation has been passed in over a dozen states to make psilocybin legal.8